Financials BioRestorative Therapies, Inc.

Stocks

Market Closed - Nasdaq 16:30:00 2026-10-30 EDT			5-day change	1st Jan Change
1.400 ^USD	-11.37%		-13.56%	-94.04%

10-09	BioRestorative Therapies, Inc. Announces Board and Committee Changes	CI
10-06	Maxim Downgrades BioRestorative Therapies to Hold From Buy	MT

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	0.046	0.1198	0.1458	0.401	0.3597	0.31	1.5	2.5
Change	-	160.43%	21.7%	175.03%	-10.3%	-13.82%	383.87%	66.67%
EBITDA	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EBIT ¹	-26.31	-18.97	-15.22	-11.56	-15.65	-16.82	-16.54	-16.48
Change	-	27.88%	19.78%	24.08%	-35.41%	-7.47%	1.67%	0.31%
Interest Paid	-	0.0116	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-44.3	-18.49	-14.42	-8.979	-14.24	-16.64	-16.32	-16.2
Change	-	58.25%	22.06%	37.71%	-58.61%	-16.81%	1.91%	0.72%
Net income ¹	-44.3	-18.49	-14.42	-8.979	-14.24	-16.64	-16.32	-16.2
Change	-	58.25%	22.06%	37.71%	-58.61%	-16.81%	1.91%	0.72%
Announcement Date	3/30/22	3/27/23	4/1/24	3/28/25	3/26/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q4	2022 Q1	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	0.005	0.016	0.029	0.0037	0.0313	0.0645	0.0307	0.0193	0.035	0.0891	0.2336	0.0433	0.025	0.3033	0.0118	0.0196	0.0232	0.07	0.09	0.1
Change	-	-	220%	81.25%	-87.24%	745.95%	106.07%	-52.4%	-37.13%	81.35%	154.57%	162.18%	-81.46%	-42.26%	1,113.2%	-96.11%	66.1%	18.21%	202.11%	28.57%	11.11%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-	-4.009	-5.054	-4.61	-4.682	-5.779	-3.117	-3.104	-3.221	-4.109	-2.469	-2.287	7.71	-4.808	-3.305	-3.709	-3.825	-3.386	-3.884	-3.905	-3.936
Change	-	-	-26.05%	8.79%	-1.57%	-23.43%	46.07%	0.39%	-3.74%	-27.59%	39.92%	7.36%	437.12%	-162.36%	31.25%	-12.21%	-3.14%	11.49%	-14.72%	-0.54%	-0.79%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-	-	-4.656	-4.348	-5.684	-2.981	-2.925	-2.825	-2.223	-4.029	-1.091	-1.636	-5.34	-2.656	-3.038	-3.208	-2.154	-3.814	-3.855	-3.906
Change	-	-	-	-	6.62%	-30.75%	47.56%	1.85%	3.43%	21.31%	-81.2%	72.91%	-49.91%	-226.36%	50.26%	-14.38%	-5.57%	32.84%	-77.03%	-1.07%	-1.32%
Net income ¹	-4.063	-20.4	-4.816	-4.656	-4.348	-5.684	-2.981	-2.925	-2.825	-2.223	-4.029	-1.091	-1.636	-5.34	-2.656	-3.038	-3.208	-2.154	-3.814	-3.855	-3.906
Change	-	-402.22%	76.4%	3.33%	6.62%	-30.75%	47.56%	1.85%	3.43%	21.31%	-81.2%	72.91%	-49.91%	-226.36%	50.26%	-14.38%	-5.57%	32.84%	-77.03%	-1.07%	-1.32%
Announcement Date	8/16/21	3/30/22	5/16/22	11/14/22	3/27/23	5/12/23	8/11/23	11/13/23	4/1/24	6/11/24	8/13/24	11/12/24	3/28/25	5/14/25	8/12/25	11/12/25	3/26/26	5/14/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	3/30/22	3/27/23	4/1/24	3/28/25	3/26/26	-	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025
CAPEX ¹	-	0.0307	0.2652	0.171	0.1062	0.1161
Change	-	-	765.1%	-35.51%	-37.92%	9.3%
Free Cash Flow (FCF) ¹	-6.312	5.705	0.6117	-1.081	-3.11	-6.2
Change	-	190.38%	-89.28%	-276.67%	-187.81%	-99.34%
Announcement Date	4/30/21	3/30/22	3/27/23	4/1/24	3/28/25	3/26/26

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-57,191.02%	-15,838.09%	-10,439.49%	-2,881.59%	-4,350.05%	-5,424.52%	-1,102.33%	-659.32%
EBT Margin (%)	-	-96,311.52%	-15,438.04%	-9,887.16%	-2,239.25%	-3,959.41%	-5,366.45%	-1,087.93%	-648.08%
Net margin (%)	-	-96,311.52%	-15,438.04%	-9,887.16%	-2,239.25%	-3,959.41%	-5,366.45%	-1,087.93%	-648.08%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-59.18%	-122.7%	-60.99%	-65.5%	-58.03%	-119.56%	-	-	-
ROE	159.81%	-437.23%	-98.83%	-105.3%	-96.89%	-320.47%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-0.66x	-	-	-	-	-	-	-	-
Debt / Free cash flow	-0.27x	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-746	-102.2	-68.4	-23.2	-31.6	-13.2	-10.4	-9.8
Change	-	-	86.3%	33.07%	66.08%	-36.21%	58.23%	21.21%	5.77%
Nbr of stocks (in thousands)	-	175	184	235	346	444	1,274	1,274	1,274
Announcement Date	-	3/30/22	3/27/23	4/1/24	3/28/25	3/26/26	-	-	-